首页> 美国卫生研究院文献>Scientific Reports >An in vivo wound healing model for the characterization of the angiogenic process and its modulation by pharmacological interventions
【2h】

An in vivo wound healing model for the characterization of the angiogenic process and its modulation by pharmacological interventions

机译:用于表征血管生成过程及其药理学干预作用的体内伤口愈合模型

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Angiogenesis during wound healing is essential for tissue repair and also affected during cancer treatment by anti-angiogenic drugs. Here, we introduce a minimally invasive wound healing model in the mouse ear to assess angiogenesis with high spatiotemporal resolution in a longitudinal manner in vivo using two-photon microscopy in mice expressing GCaMP2 in arterial endothelial cells. The development of vascular sprouts occurred in a highly orchestrated manner within a time window of 8 days following wounding. Novel sprouts developed exclusively from the distal stump of the transsected arteries, growing towards the proximal arterial stump. This was in line with the incidence of Ca2+ transients in the arterial endothelial cells, most probably a result of VEGF stimulation, which were more numerous on the distal part. Functional analysis revealed perfusion across the wound site via arterial sprouts developed between days 6 and 8 following the incision. At day 8, proximal and distal arteries were structurally and functionally connected, though only 2/3 of all sprouts detected were actually perfused. Treatment with the FDA approved drug, sunitinib, the preclinical drug AZD4547, as well as with the combination of the two agents had significant effects on both structural and functional readouts of neo-angiogenesis. The simplicity and high reproducibility of the model makes it an attractive tool for elucidating migratory activity, phenotype and functionality of endothelial cells during angiogenesis and for evaluating specific anti-angiogenic drug interventions.
机译:伤口愈合过程中的血管生成对于组织修复至关重要,在抗血管生成药物的癌症治疗过程中也会受到影响。在这里,我们在小鼠耳中引入一种微创伤口愈合模型,以在体内使用双光子显微镜在动脉内皮细胞中表达GCaMP2的小鼠中以纵向方式评估具有高时空分辨率的血管生成。受伤后8天之内,以高度协调的方式发生了血管发芽。新型芽仅从横切的动脉的远端残端发育,向近端的动脉残端生长。这与动脉内皮细胞中Ca 2 + 瞬变的发生率一致,这很可能是VEGF刺激的结果,在远端部分数量更多。功能分析显示,在切口后第6天到第8天之间,通过动脉发芽在伤口部位进行了灌注。在第8天,近端和远端动脉在结构和功能上均已连接,尽管实际上仅检测到所有萌芽的2/3。使用FDA批准的药物舒尼替尼,临床前药物AZD4547以及两种药物的联合治疗对新血管生成的结构和功能读数均具有显着影响。该模型的简单性和高可重复性使其成为阐明血管生成过程中内皮细胞的迁移活性,表型和功能性以及评估特定抗血管生成药物干预措施的有吸引力的工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号